SANGBOCo상보
027580 · KOSDAQ · ₩027580 · 상보
₩1,600▼ ₩70 (4.19%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩10B | ₩8.9B | ₩10B | ₩13B | ₩15B | ₩12B | ₩11B | ₩14B |
| Cost of sales | ₩9.3B | ₩8.6B | ₩9.7B | ₩11B | ₩12B | ₩11B | ₩10B | ₩11B |
| Gross profit | ₩908M | ₩304M | ₩304M | ₩1.3B | ₩3.3B | ₩1.6B | ₩342M | ₩3.8B |
| Operating income | −₩2.6B | −₩3.4B | −₩4.7B | −₩2.1B | −₩466M | −₩1.7B | −₩6.9B | ₩75M |
| Net income | ₩76M | −₩2.7B | −₩12B | ₩499M | ₩611M | −₩2.4B | −₩9.9B | −₩2.3B |
| Net income to shareholders | −₩2.6B | −₩2.7B | −₩7.4B | −₩1.3B | −₩1.7B | −₩2.4B | −₩11B | −₩1B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩88B | ₩91B | ₩94B | ₩98B | ₩102B | ₩102B | ₩105B | ₩114B |
| Current assets | ₩56B | ₩59B | ₩59B | ₩65B | ₩68B | ₩66B | ₩68B | ₩72B |
| Cash and equivalents | ₩6.6B | ₩4.3B | ₩5.5B | ₩4B | ₩6B | ₩6.5B | ₩9.1B | ₩14B |
| Total liabilities | ₩49B | ₩50B | ₩51B | ₩53B | ₩55B | ₩54B | ₩54B | ₩53B |
| Current liabilities | ₩41B | ₩41B | ₩42B | ₩44B | ₩46B | ₩45B | ₩46B | ₩45B |
| Borrowings | ₩34B | ₩34B | ₩34B | ₩34B | ₩34B | ₩36B | ₩36B | ₩36B |
| Total equity | ₩39B | ₩41B | ₩43B | ₩45B | ₩47B | ₩49B | ₩51B | ₩61B |
| Shareholders' equity | ₩39B | ₩41B | ₩43B | ₩45B | ₩47B | ₩49B | ₩51B | ₩61B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩2.2B | −₩2.3B | −₩952M | −₩3.6B | ₩30M | −₩2.6B | ₩985M | −₩2.5B |
| Capital spending | ₩138M | ₩266M | −₩317M | ₩104M | ₩303M | ₩515M | ₩534M | ₩81M |
| Free cash flow | −₩2.3B | −₩2.5B | −₩1.3B | −₩3.7B | −₩272M | −₩3.2B | ₩451M | −₩2.6B |
Consolidated where available. Amounts in won.
Also known as: SANGBOCo / 상보 / 027580 / KRX:027580
Source: KRX statistical information